Tango Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 94
Employees
  • Stock Symbol
  • TNGX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $8.37
  • (As of Monday Closing)

Tango Therapeutics General Information

Description

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Contact Information

Website
www.tangotx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 100 Binney Street
  • Suite 700
  • Cambridge, MA 02142
  • United States
+1 (857) 000-0000

Tango Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tango Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.37 $8.35 $7.50 - $18.84 $731M 87.5M 136K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tango Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tango Therapeutics‘s full profile, request access.

Request a free trial

Tango Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Tango Therapeutics‘s full profile, request access.

Request a free trial

Tango Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering
Drug Discovery
Cambridge, MA
94 As of 2021
00000
000000000000 00000

0000 000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 000000000
Basel, Switzerland
00 As of 0000
000.00
000000000 000.00

000 0000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tango Therapeutics Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FoRx Therapeutics Venture Capital-Backed Basel, Switzerland 00 000.00 000000000 000.00
000 000000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed Lexington, MA 00 00000 00000000 00000
0000000000 0000000 Venture Capital-Backed Hamburg, Germany 0 000.00 0000000000 0 000.00
0000000 Formerly VC-backed New Haven, CT 000 00000 000000 - 000 00000
You’re viewing 5 of 43 competitors. Get the full list »

Tango Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Tango Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11077101-B1 Compounds and methods of use Active 18-Jul-2018 00000000000 00

Tango Therapeutics Executive Team (22)

Name Title Board Seat Contact Info
Barbara Weber MD Chief Executive Officer & Board Member
Daniella Beckman Chief Financial Officer, Finance
Alan Huang Ph.D Chief Scientific Officer
Alan Ashworth Ph.D Co-Founder
Jose Baselga Ph.D Co-Founder
You’re viewing 5 of 22 executive team members. Get the full list »

Tango Therapeutics Board Members (12)

Name Representing Role Since
Aaron Davis Boxer Capital Board Member 000 0000
Alexis Borisy Third Rock Ventures Board Member 000 0000
Barbara Weber MD Tango Therapeutics Chief Executive Officer & Board Member 000 0000
Cary Pfeffer MD Third Rock Ventures Board Member 000 0000
Lesley Calhoun Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Tango Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tango Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tango Therapeutics‘s full profile, request access.

Request a free trial

Tango Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 10-Aug-2021 0000000000 Special Purpose Acquisition Company (SPAC)
To view Tango Therapeutics’s complete acquisitions history, request access »